Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies
RepIntel reimagines pharmaceutical outreach as a core layer of global health infrastructure, channeling lifesaving therapies to those who need them most. NEW YORK, NY, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- Aletheia Capital Endeavours ( …